Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service ERCP & endoscopic ultrasound cases in South Dakota: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 5% on average (240 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 7 | 302 | 23% |
| 2020 | 7 | 383 | 25% |
| 2021 | 6 | 349 | 28% |
| 2022 | 6 | 321 | 32% |
| 2023 | 5 | 314 | 36% |
| 2024 | 5 | 279 | 39% |
| 2025 from claims | – | 334 270–392 | 41% |
| 2026 forecast | – | 356 279–447 | 39% |
| 2027 forecast | – | 365 271–483 | 39% |
| 2028 forecast | – | 374 265–517 | 39% |
| 2029 forecast | – | 384 261–550 | 40% |
| 2030 forecast | – | 393 258–583 | 40% |
Biliary stenting, stone extraction, EUS with FNA; the advanced-endoscopy call point. Professional codes (what the surgeon bills): CPT 43264, 43274, 43260, 43259, 43242, 43266.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in South Dakota; 3 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 57% inpatient hospital, 43% hospital outpatient.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Illinois | 80 | 5,038−0.4%/yr | −0.4%/yr | 3.7 | 1% | 6,770 in 2030+5.1%/yr |
| Missouri | 46 | 4,278−2.6%/yr | −2.6%/yr | 7.1 | 2% | 4,480 in 2030+0.8%/yr |
| Ohio | 60 | 3,607−1.1%/yr | −1.1%/yr | 3.3 | 1% | 4,620 in 2030+4.2%/yr |
| Michigan | 53 | 3,574+1.2%/yr | +1.2%/yr | 4.3 | 1% | 4,510 in 2030+4%/yr |
| Indiana | 42 | 2,562−1%/yr | −1%/yr | 3.7 | 3% | 3,260 in 2030+4.1%/yr |
| Minnesota | 37 | 2,446−5.1%/yr | −5.1%/yr | 5.5 | 3% | 3,110 in 2030+4.1%/yr |
| Wisconsin | 40 | 1,723−4.1%/yr | −4.1%/yr | 3.1 | 0% | 1,930 in 2030+1.9%/yr |
| Nebraska | 11 | 985−1.3%/yr | −1.3%/yr | 3.8 | 3% | 1,130 in 2030+2.4%/yr |
| Kansas | 10 | 846−4%/yr | −4%/yr | 2.1 | 2% | 840 in 2030−0.2%/yr |
| Iowa | 11 | 822−0.4%/yr | −0.4%/yr | 1.9 | 1% | 920 in 2030+2%/yr |
| North Dakota | 7 | 463+12%/yr | +12%/yr | 4.7 | 0% | 800 in 2030+9.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 70 | 15,668−1.4%/yr | −1.4%/yr | 124.21.1× | 20% | 16,700 in 2030+1%/yr |
| Bronchoscopy & lung nodule | 8 | 310+7.1%/yr | +7.1%/yr | 2.40.7× | 0% | 620 in 2030+12%/yr |
ERCP & endoscopic ultrasound in every state, and its device makers · Every procedure market in South Dakota · Every state · Compare with Illinois
Boston Scientific leads with 50% of company spending on these surgeons in 2025, −36 pts on 2024.
In 2025, 4 companies reported engagement with South Dakota’s surgeons worth $2,127 in consulting, speaking, meals and travel tied to these products, about $425 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 2 clearances and approvals in the category, 7 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.